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Health information exchange (HIE) projects are sweeping the nation, with hopes that they will lead to high quality, eﬃcient care, yet the
literature on theirmeasured beneﬁts remains sparse. To the degree that the ﬁeld adopts a common set of evaluation strategies, duplicatework
can be reduced andmeta-analysis will be easier. TheUnitedHospital Fund sponsored ameeting to addressHIE evaluation.HIEprojects are
diverse with many kinds of eﬀects. Assessment of the operation of the HIE infrastructure and of usage should be done for all projects. The
immediate business casemust be demonstrated for the stakeholders.Rigorous evaluationof the eﬀect onqualitymayonlyneed tobedone for
a handful of projects, with simpler process studies elsewhere. Unintended consequences should be monitored. A comprehensive study of
return on investment requires an assessment of all eﬀects. Program evaluation across several projects may help set future policy.
 2007 Elsevier Inc. All rights reserved.
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Health information exchange (HIE) projects—which are
often run by regional health information organizations—
may be a stepping stone to a fully interoperable health
information infrastructure that improves the quality and
eﬃciency of health care in the United States. Around the
nation, there are a few successful networks [1], but there
are many initiatives and networks in their early stages.1532-0464/$ - see front matter  2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.jbi.2007.08.002
* Corresponding author. Fax: +1 212 543 8788.
E-mail address: hripcsak@columbia.edu (G. Hripcsak).The literature on the measured beneﬁts of HIE remains
sparse. In addition, most previous ﬁnancial evaluations
were based on expert panel estimates rather than on pri-
mary data [2]. The real ﬁnancial and clinical beneﬁts of
these technologies therefore remain unclear. For example,
while the Patient Safety Institute predicted a 20-to-1 return
on investment at the national level for clinical data
exchange [3], the 2003 Interim Report on the Santa Bar-
bara County Data Exchange predicted only a marginal
positive return on investment for the implementers [4].
Overhage et al. [5] found a $26 savings per emergency
department patient due to clinical data exchange in one
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in public health reporting [6] and savings in test ordering [7]
have been noted. Models predict large beneﬁts [2], but
these are based on predictions from an aggregate of indi-
vidual studies and expert opinion rather that observation
of actual HIE implementation. The net of this is that the
ﬁnancial returns of HIE are uncertain.
More broadly, we do not have suﬃcient information to
judge whether local HIE eﬀorts will be viable in the long
run and whether they will be the best approach to develop-
ing a national infrastructure. Despite the number of HIE
projects currently in progress, there is a risk that we might
learn little from these projects due to limited resources, lack
of focus, and limited experience in evaluation.
To help address these issues, a meeting was funded by
the United Hospital Fund and convened on November
1–2, 2006 in New York City, NY. Experts on HIE and
experts on evaluation gathered to discuss HIE evaluation
and address how to create an HIE evaluation framework.
The result of that discussion is summarized in this report.
2. Health information exchange and its eﬀects
Studying the impact of HIE requires understanding the
many kinds of eﬀects of HIE. In general, HIE projects
begin with a primary use case or set of use cases that rep-
resent the main purpose or thrust of the project. There may
be secondary use cases from the conception, or they may
arise as the project matures. There may also be unintended
and unexpected uses and misuses of the project’s informa-
tion system.
An HIE project undergoes a series of steps, from early
conception to mature maintenance. Reviewing the steps
can uncover possible unintended and unexpected eﬀects.
In the planning stages, the idea of the HIE project arises
in some stakeholder. The stakeholder works to ﬂesh out
the idea and build support among the other stakeholders,
including provider organizations, clinicians, payers, plans,
residents, business groups, and government. Initial formal
participants are selected, use cases become more concrete,
and the business case is developed including identifying ini-
tial sources of funding or resources. In reality, many pro-
jects are conceived in a given locale, and some number of
them may merge to form a viable project. Eventually, a
detailed initial plan is developed and implementation
begins.
The style of implementation may vary, but in general
there is some speciﬁcation of requirements, a decision on
how to implement, the purchase or development of soft-
ware, the acquisition of hardware, and the development
of interfaces. Privacy and security policies are developed.
Depending on the design, various databases may be popu-
lated: record locator service, a central data repository, or
edge servers. Users are trained. An evaluation plan is devel-
oped and baseline measures may be taken. The user appli-
cation is deployed in the user’s locations. Operation
includes the normal operation and the problems such asdowntime, slow response, and bugs. Development is ongo-
ing and the use case evolves and expands.
Use cases are diverse. The primary ones often involve
improving information access for clinical care. The provid-
ers that stand to beneﬁt the most are those that provide
care on entry to the system, such as private oﬃces, clinics,
and emergency departments. The HIE project generally ﬁlls
a knowledge deﬁcit, be it recognized or not. Data may be
pulled (the user explicitly requests data for a patient,
acknowledging a deﬁcit) or pushed (the user receives unso-
licited data, potentially ﬁlling an unknown deﬁcit). It may
be focused on a speciﬁc area such as cardiology, or broadly
deﬁned to address medication safety. Some use cases
emphasize care eﬃciency rather than quality and decision
making. For example, electronic data exchange may be
cheaper and faster than traditional paper laboratory
reports. Use cases may involve other stakeholders besides
clinicians, such as researchers and public health
departments.
Fig. 1 shows one delineation of the causes and eﬀects for
a primary use case. Planning, implementation, and opera-
tion result in direct costs. Operation of the intervention
has eﬀects on the health care process, which, in turn,
should aﬀect health care outcomes. There may also be
unintended consequences and risks that aﬀect outcomes.
These various eﬀects may have ﬁnancial consequences.
Fig. 2 shows a broader range of eﬀects. HIE components
and activities result in a variety of eﬀects, which can then
have ﬁnancial consequences. There may also be negative
and positive unintended and unexpected eﬀects. For exam-
ple, the process of generating support may have eﬀects in
the community beyond the concrete provision of data. Ear-
lier failures may facilitate future HIE projects by introduc-
ing the idea of data exchange, by seeding future ideas of
feasible data exchange. It may also impede future projects
by setting expectations of failure. Researchers who are
evaluating HIE should consider these many eﬀects in
designing their studies.
3. Issues in evaluating health information exchange
There is clearly a need for evaluation to determine the
eﬀect of HIE on the quality and eﬃciency of care and to
determine the return on investment for society and stake-
holders. The AHRQ HIE Toolkit [8] provides a general
approach to health information technology evaluation
and examples of what can be evaluated, but it does not pro-
vide a roadmap for moving forward. What is needed at the
present time is not another toolkit, but a public framework
that serves, in eﬀect, as a meta-toolkit. That is, the frame-
work should guide in the selection from among the many
possible factors that can be studied. Agreeing on a set of
methodologies will reduce duplicated eﬀort in designing
studies and will enable future meta-analysis.
One challenge to agreeing on a set of methodologies is
the realization that there is no single model for HIE. The
term covers a broad range of health information technology
Planning and implementation
Direct costs
Immediate effects of knowledge on health care process
Avoid repeated diagnostic test 
Add diagnosis to differential (e.g., know pt. is diabetic) 
Drop diagnosis from differential (e.g., r/o MI by ECG) 
Earlier add or drop of diagnosis (e.g., shorten time to therapy) 
Choose appropriate test 
Choose appropriate therapy 
Uncover contraindication to therapy (e.g., allergy) 
Uncover need to modify therapy (e.g., dosing) 
Raise confidence that subsequent clinician will see current data 
Reduce time tracking down information 
Intended operation
Push or pull data to clinicians 
Fill known knowledge deficit 
Fill unknown knowledge deficit 
Prevent future knowledge deficit 
Effect on outcomes
Quality
Reduced adverse events 
Reduced morbidity 
Reduced mortality 
Utilization
Reduced admissions (first, repeat, elsewhere) 
Reduced length of stay 
Reduced diagnostic tests 
Productivity
Reduced provider time 
Reduced data transfer costs 
Financial consequences
Provider organizations 
Payers
Clinicians
Patients
Government
Risks and negative effects
Inaccurate data causing an error 
Returning data on the wrong patient 
False sense of security about lack of data 
Downtime and loss of productivity 
Loss of patient privacy (opt out or wrong patient) 
Time cost to clinician to use system
Fig. 1. Focus on primary eﬀects.
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evaluation will therefore be diﬃcult. It may be more pro-
ductive to treat HIE not as a single entity, but as a range
of health information technologies that happen to have
an information exchange component. Therefore, it may
require a range of evaluations to learn from the diversity
of HIE projects. Focusing too quickly on a narrow set of
methodologies may limit what can be learned.
There are a number of concrete HIE evaluation initia-
tives already in progress. One of the most mature is the
Indiana Health Information Exchange, which began withthe Indiana Network for Patient Care in 1993. The net-
work has 280 data sources from an entire region that ﬂow
via Health Level Seven into a queue and a database with
over 600 million observations. A set of services are built
on top of this infrastructure, including emergency depart-
ment access, ambulatory practice message routing, anony-
mous querying of pathology reports, and syndromic
surveillance. Each service has an expected outcome and
pays its share of the infrastructure. Clinical messaging,
for example, saves $30 million per year with 150,000 mes-
sages per day. One ten-doctor practice saved $160,000
HIE components and activities
Planning
Generate idea 
Gather community support 
Enlist participants 
Raise funds 
Develop business model 
Develop privacy plan 
Develop technical design 
Implementation
Specify requirements 
Adopt standards 
Select vendor selection or develop software 
Acquire hardware 
Train users 
Populate databases (RLS, clinical databases) 
Deploy
Downtime, slow response, bugs 
Evaluate
Intended operation 
Users query for clinical information based on a 
perceived deficit 
Clinical information is pushed to users during 
visits
Data are pushed to research databases 
Data are pushed to public health departments 
Effects of HIE
Direct costs 
Hardware
Software
Training
Personnel
Risks and negative effects 
Inaccurate data causing an error 
Returning data on the wrong patient 
False sense of security about lack of data 
Downtime and loss of productivity 
Loss of patient privacy (opt out or wrong patient) 
Time cost to clinician to use system 
Loss of business privacy 
Disappointment in HIE following failure 
Liability
Health care quality improvements 
Fill known knowledge deficit 
Fill unknown knowledge deficit (via push or search 
for other information) 
Use of clinical data for population disease 
management
Use of RLS and clinical databases for disaster 
management
Health care efficiency improvements 
Facilitate referrals 
Reduce wasted effort retrieving information 
Reduce more costly alternative methods of sharing 
information (e.g., mail, phone) 
Profits
Sale of data 
Advertising revenue 
Other benefits and consequences (including the HIE 
planning activities) 
Clinical job satisfaction 
Patient satisfaction or disappointment 
Facilitate EHR adoption 
Facilitate standards adoption 
Increased coordination of health care business 
activities in region 
Improved IT infrastructure 
Unexpected consequences 
Related attributes 
Usage (not a direct benefit or consequence, but 
mediates the effects) 
Financial consequences
Direct costs 
Estimated cost of risks, consequences 
Estimated value of benefits, profits 
Fig. 2. Summary of all eﬀects.
S6 G. Hripcsak et al. / Journal of Biomedical Informatics 40 (2007) S3–S10per year in physician and staﬀ time. The overall evaluation
approach is to assess each service in its own context rather
than to establish a common evaluation plan.
The MidSouth eHealth Alliance in Memphis, Tennessee
is one of the more advanced recent projects. Its ﬁrst use
case is sharing information for review in emergency depart-
ments. Its evaluation team plans to assess cost, use and
usability, clinical outcomes of disease-speciﬁc hypotheses(neonatal group B ß-hemolytic streptococcus, asthma, con-
gestive heart failure, and immunization), dollars saved in
the care delivery process, and workﬂow gains. At present,
the control strategy is being worked out: compare patients
with data in the HIE database to patients without data or,
of patients who do have data in the database, compare
patients who had data accessed to those who did not have
data accessed. In the former case, it is diﬃcult to gather
G. Hripcsak et al. / Journal of Biomedical Informatics 40 (2007) S3–S10 S7data on the control patients, although claims data may suf-
ﬁce. Biases may arise, because patients may not have data
in the database due to opting out or being treated at a loca-
tion that cannot send data. Early evaluation of their HIE
infrastructure has shown problems they did not expect,
such as increased data latency.
New York State allocated $53 million for the ﬁrst phase
of its Health Care Eﬃciency and Aﬀordability Law for
New Yorkers Capital Grant Program (HEAL NY Pro-
gram) [9] to address HIE and other health information
technology. Twenty-six grants were awarded, with nine in
New York City. The Health Information Technology Eval-
uation Center (HITEC) was created to evaluate the pro-
gram. HITEC initially planned six types of evaluation:
usage, ﬁnancial, quality, safety, consumer satisfaction,
and provider satisfaction. HITEC has a joint role: to facil-
itate the evaluation of individual HIE projects and to eval-
uate the HEAL NY Program as a whole. It is likely that
some of these projects will succeed and some will fail,
and the HITEC evaluation will enable the correlation of
strategy with success and failure. In addition, in many of
these failures will be hidden successes, such as the seeds
for a future successful project. Therefore, when it is com-
pleted, the HITEC evaluation will hopefully tell the policy
story of what is happening in New York and provide infor-
mation about broad programs, not just individual projects.
In practice, HITEC will begin with six projects that will
be selected via an environmental scan. The scan includes
market characteristics, organization and governance, per-
ceived barriers to success, technologic aspects, strategic
vision, and capacity for research. The HITEC has found
that just talking to the project leaders has in some cases
resulted in them adjusting their interventions and evalua-
tions. Therefore, having readily available expertise and col-
laboration may be as important to a broad program like
HEAL NY as a formal framework.
There are several possible ways to organize an HIE eval-
uation framework. It may be organized by the goal of the
evaluation. Formative evaluations steer the design of the
project and often focus on issues like usability and work-
ﬂow. Summative evaluations allow others to generalize
from the project and often focus on impact. Monitoring
is another form of evaluation that focuses on ongoing mea-
surement. A framework may be organized by the type of
evaluation. An evaluation may be a rigorous quantitative
study such as a randomized clinical trial; it may be rigorous
qualitative study such as a series of focus groups that are
analyzed using grounded theory to ascertain unintended
consequences; or it may be an operational analysis that is
designed to assess progress on a project eﬃciently (e.g.,
usage statistics).
A framework may be organized by the subject being
evaluated. For example, an HIE program may be broken
into three levels: the platform infrastructure and the oper-
ations of that platform, the interventions and services that
use the platform, and the program as a whole. The plat-
form evaluation includes usage (who, how often), breadth,completeness, and conﬁdentiality. The intervention evalua-
tion includes quantitative and qualitative iterative assess-
ment of expected eﬀects on outcome, such as mortality,
quality, safety, eﬃciency, usage, and satisfaction. The pro-
gram evaluation addresses policy and regional outcomes by
aggregating the evaluations of the interventions and by
looking at project and program characterizations.
Prioritizing evaluation methods requires understanding
the important goals of HIE and the important challenges
facing HIE. For example, one of the most diﬃcult chal-
lenges for HIE projects is securing upfront funding and cre-
ating a sustainable business model. Some successes do
exist, such as the Indiana Health Information Exchange
and the HealthBridge project in the Greater Cincinnati
tri-state area, but the challenge remains large.
The ﬁnancial impact of an HIE project can be seen from
diﬀerent points of view: the immediate business case diﬀers
from the full return on investment from a societal point of
view. For the immediate business case, the investors and
other key stakeholders must meet their ﬁnancial and pro-
grammatic objectives. A full assessment of return on
investment requires knowledge of a broader range of costs
and eﬀects. For example, there may be an eventual eﬀect on
public health that is unrelated to the interests of the initial
investors. Furthermore, analysis of return on investment is
diﬃcult because it may be diﬃcult to identify what entities
have lost income and to quantify the result. For example,
better emergency department triage may lead to fewer
admissions. Several return on investment models have been
formulated; examples include the eHealth Initiative cost
model tool and market assessment tool, the Center for
Information Technology Leadership value tool, and
return-on-investment tools that have been developed by
health plans.
A major driving force for HIE is improving the quality
of care, although it is diﬃcult to measure. HIE evaluation
should draw on existing eﬀorts in measuring quality. The
Institute of Medicine Quality Chasm report uses six fea-
tures in a quality framework: safe, eﬀective, patient-cen-
tered, timely, eﬃcient, and equitable. The Ambulatory
care Quality Alliance (AQA) has developed 26 quality mea-
sures, and they may be relevant to HIE. An informal
review of the measures revealed that most of the indicators
should show some impact, although tobacco use and
smoking cessation were thought to be less fruitful. For each
indicator area, HIE may cause better care, better documen-
tation of care, or better eﬃciency by reducing duplicate
testing. Unfortunately, the 26 measures may only be
impacted modestly by HIE, and the major eﬀects of HIE
may fall outside of the AQA measures.
One challenge in demonstrating an eﬀect on quality is
that traditional health information technology interven-
tions such as automated decision support may create a big-
ger impact than HIE itself. HIE projects that include the
new deployment of health information technology inter-
ventions should ideally separate the cost of HIE and the
incremental beneﬁt of HIE if they are to assess the true
S8 G. Hripcsak et al. / Journal of Biomedical Informatics 40 (2007) S3–S10value of the information exchange, though this will be chal-
lenging. Sample sizes need to be large enough to measure
this smaller impact.
It also remains unclear whether the quality improve-
ments found will be suﬃcient to motivate investment in
HIE, although there are of course other beneﬁts. Despite
the existing literature on the impact of health information
technology, it has been diﬃcult to obtain broad invest-
ment. HIE, with its lower impact, is therefore likely to be
even more diﬃcult. One criticism of previous evaluations
of health information technology is that most were carried
out at a few unusual health care centers. Therefore, multi-
project evaluation may be necessary to obtain suﬃcient evi-
dence about quality to encourage investment, and quality
may need to be paired with eﬃciency to achieve increased
investment.
Evaluation of the HIE platform is important to steer the
design of the project, to monitor the ongoing operation of
the project, and to oﬀer lessons to other projects. The eval-
uation includes issues around transferring data: complete-
ness, timeliness, and accuracy of data transfer, success in
matching patients, and conﬁdentiality breaches. Strictly
speaking, usage and impact studies do not apply to the
HIE platform itself, but to the intervention (service) that
uses the platform. Most of the HIE evaluation will be spe-
ciﬁc to the use cases.
HIE by deﬁnition involves transferring information
among parties that are not otherwise formally connected.
Therefore, it is diﬃcult to predict all the eﬀects of HIE,
and a rigorous assessment of the eﬀect of HIE must
include unintended consequences, both positive and neg-
ative. Unintended consequences can be measured
through a partnership between researchers with experi-
ence in uncovering unintended eﬀects and personnel
who know the project. Rapid ethnographic assessment
is an example of an approach that does not require large
investment.
Program evaluation, such as evaluation of several pro-
jects funded by one funding program, is becoming more
important as the interest in HIE grows. For example, 12
states have issued executive orders about HIE and may
beneﬁt from each other’s experience. Such programs
include a series of steps—awareness, regional activity, state
leadership, statewide planning, statewide plan, and state-
wide implementation—and each of these can undergo
evaluation.
An individual project must balance its own need for
evaluation versus the evaluation needs for the program
and society. Successful implementation strategies may be
more important in the program evaluation than proof of
return on investment or improved quality. Reasons for suc-
cess or failure are diﬃcult to sort out, however, because
cause and eﬀect are more diﬃcult to assign than associa-
tion. For example, following a checklist of HIE implemen-
tation steps will not guarantee success, but failing to follow
those steps may be symptomatic of deeper problems that
will lead to failure.A rule of thumb for evaluation is that you must spend
10% of the budget on evaluation in order to learn from
what you are doing. Not all evaluations need to be done
on every project, however. Thus, for example, a rigorous
evaluation of the quality impact of an HIE intervention
may only need to be done three times if the results are con-
sistent. After that, process measures may suﬃce to conﬁrm
that the intervention is functioning as intended. Similarly,
time-motion studies need not be repeated endlessly.
Evaluation takes time. Many clinical eﬀects may not be
seen until 18 months after launching the eﬀort and it may
take 6 months to gather data, so there may be a 2-year lag
from launching to demonstrating an eﬀect. Therefore, clini-
cal outcomemaybe toodiﬃcult to assess on the ﬁrst roundof
evaluation.Nevertheless, itmaybe important to gather base-
line data early and to inﬂuence how the project is being con-
ﬁgured and learn what data elements need to be collected.
Process measures will be available faster than outcomes.
Patient safety eﬀects may occur quickly, but a large sample
size is required to detect them; looking for medication
errors rather than actual adverse drug events will dramati-
cally lower the required sample size. The immediate busi-
ness case (e.g., reduce cost disseminating laboratory
results) will be faster than a full return-on-investment anal-
ysis that includes all costs and beneﬁts. Gathering stories
about how HIE has helped the health care process may cre-
ate enough incentive for investors until hard evidence
about return on investment arrives. This is one of the eval-
uation thrusts of the MidSouth eHealth Alliance.
Carrying out a good evaluation is a balancing act. Like
the man in the joke in which he looks for his keys under the
lamppost rather than where he dropped them because the
light is better there, we tend to measure what is easy to
measure rather than what needs to be measured. The eval-
uation must be both feasible and useful, but it will never be
perfect.
In summary, HIE has no eﬀect until the platform is put
to some concrete use. Every project should carry out some
platform-level monitoring, such as measuring data move-
ment by user and data type. Projects can tailor their inter-
vention-speciﬁc evaluation to the likely impact of the
intervention, the timeframe, and the evaluation budget.
The AQA measures are a starting point for some quality
interventions, but more sensitive indicators should be used
if possible. Not every HIE project should attempt to carry
out the same detailed quality study; as a rough guide about
three similar evaluations need to be published. The busi-
ness case for each project should be evaluated. At the pol-
icy level, the impact of broad programs like the HEAL NY
Program should be assessed.
4. Evaluation priorities
Based on the analysis of the eﬀects of HIE and on the
above discussion, HIE evaluation can be organized into a
series of steps or foci. Assume that an HIE project has a
data exchange platform, a primary use case for that plat-
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ject is part of a larger program. The steps are ordered here
roughly by complexity and by the time required to com-
plete them.
4.1. Platform evaluation
The information exchange infrastructure must undergo
initial evaluation to verify its success, and it must be mon-
itored over the course of the project. Data transfer may be
assessed in terms of accuracy, completeness, and timeliness;
these concepts may need to be deﬁned in terms of the pri-
mary use case. Patient matching should be veriﬁed. The
system (software running on the hardware platform) can
be characterized by uptime and performance.
4.2. Usage studies
Given the primary use case, usage can be measured.
Important features include who is using the system and
how much. This can usually be accomplished eﬃciently
based on the system’s audit logs. User satisfaction and sys-
tem usability may also be assessed through surveying, focus
groups, observation, or usability laboratories.
4.3. Immediate business case
For the project to stay in operation, the immediate busi-
ness case must be assessed. It may be based on the direct
costs of the project and the measurable projected ﬁnancial
beneﬁts. The business case serves to reassure the investors
and other key stakeholders that the project is proceeding
as expected with a reasonable proﬁt or cost-beneﬁt ratio.
4.4. Assessment of clinical and administrative impact
Beneﬁts such as quality improvements take more time
and are more diﬃcult to measure. Actual demonstration
that the HIE project has caused improvement in clinical
outcomes is most diﬃcult and requires a large controlled
trial. Such studies need not be duplicated in every HIE pro-
ject; three or so may be enough. After that, conﬁrmation
that process variables are improving may serve as suﬃcient
evidence that the HIE project is clinically successful.
4.5. Unintended consequences
Qualitative evaluation techniques can be used to ﬁnd
unintended and unexpected eﬀects, both positive and
negative.
4.6. Comprehensive return on investment
The full return on investment can be calculated only
after the direct and indirect costs are estimated and the
clinical and administrative impact is measured and
assigned a value. Unintended consequences must beincluded. There is the overall return on investment to soci-
ety, and there are the individual returns for the distinct
stakeholder groups.
4.7. Program evaluation
Assuming the project is part of a larger program, the
program itself can be assessed, and the results for the indi-
vidual projects can be aggregated. Knowledge of the fac-
tors that may have led to the success or failure of
individual projects may help future projects and other pro-
grams. The characteristics of the program, such as the
funding model and requirements, can be correlated with
overall success of its projects and used to develop policy
for the future.
Referring to the hopes for the HEAL NY Program,
participant David Liss (New York-Presbyterian) oﬀered a
projected sequence of evaluation results as a series of hypo-
thetical annual headlines:
• Health care providers are talking to each other.
• The network is built.
• Man in Syracuse has his life saved by a doctor in New
York City.
• New York State saves millions of dollars.
• New Yorkers are healthier.
If the program is indeed this successful, it would be a
shame not to realize it due to failed or insuﬃcient evalua-
tion. With an appropriate evaluation strategy, society can
learn of its successes and failures and use the information
to improve HIE in the future.
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